Accuray reported $116.17M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 154.45M 850K Sep/2026
Boston Scientific USD 5.14B 300M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Inogen USD 74.93M 504K Sep/2024
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Tandem Diabetes Care USD 283.69M 29.09M Sep/2026
Trinity Biotech USD 10.85M 226K Mar/2026